How are drug development and clinical trials changing?
Changing epigenetic markers in CLL patients on ibrutinib
Overcoming the challenges of evolving standards of care in CLL: advice for community physicians
Highlights from the 2016 European Multiple Myeloma Academy (EMMA) and overview of EMMA 2017
Jesús San Miguel
How to reduce anxiety levels in patients undergoing bone marrow biopsy